Full-Time
Senior Product Quality Engineer
Noah Medical
201-500 employees
Medical robotics system for lung diagnostics
Compensation Overview
$120.6k - $150.8k/yr
San Carlos, CA, USA
Hybrid
Hybrid role; remote or onsite within California per team/role.
 QA & Testing (1) |
|---|
- B.S. or M.S. in mechanical engineering or related engineering discipline
- Minimum 7 years of experience in the medical device industry
- Demonstrated history of applying creative problem solving ability to difficult technical problems
- At least 5 years of leading root cause efforts of clinical context and use of medical devices
- Ability to manage and analyze large sets of data and effectively communicate results of data analysis
- Proficient in use of computer-aided design
- Experience assessing products produced by various fabrication methods used in single use, complex medical devices (e.g. machining, plastic injection molding, metal injection molding, laser cutting, stamping, rapid prototyping)
- Demonstrated ability to work and mentor successfully in a team environment
- Demonstrated strong project management skills
- Eagerness to learn and to contribute to state of the art technology
- Lead efforts into the investigation of returned field devices, including flexible endoscopes, disposable devices, and capital devices/equipment
- Take the lead on methodical root cause analysis projects. Document the findings in clearly written reports/presentations
- Review engineering drawings, understand their impact on parts received, and propose opportunities for design improvements
- Design of test methods and fixtures in order to facilitate efficient study of returned devices
- Mentor less experienced engineers in the process of effective root cause analysis.
- Collaborate with design, manufacturing, and quality teams to drive consistent, high-quality parts and assemblies
NoahMed develops medical robotics systems for pulmonology, focusing on early diagnosis. Its flagship Galaxy System with TiLT+ Technology mitigates CT-to-body divergence to improve diagnostic yield and provides real-time navigation updates in all lung areas. It features an augmented fluoro overlay that guides locating non-visual lesions and a single-use bronchoscope with accessories to reduce cross-contamination and speed turnover, all in a compact, single-cart design for crowded operating rooms. The company differentiates itself through TiLT+ navigation, real-time augmented guidance, and a disposable—rather than reprocessed—bronchoscope setup, aiming to improve diagnostic confidence and efficiency. Its goal is to enhance early lung diagnosis with more reliable guidance, reducing procedure time and improving outcomes for patients in collaboration with interventional pulmonologists.
Company Size
201-500
Company Stage
Series B
Total Funding
$150M
Headquarters
Redwood City, California
Founded
2018
Simplify's Take
What believers are saying
- FDA clearance in March 2023 enabled first US use at University of Chicago.
- $150M Series B led by SoftBank Vision Fund fuels Galaxy expansion.
- 95% diagnostic accuracy in Cleveland Clinic's 100-patient study.
What critics are saying
- Intuitive Surgical's Ion holds 80% market share, locking hospitals.
- FDA safety notice on navigation errors halts Galaxy US expansion.
- J&J's Ottava approval undercuts single-use accessory pricing by 25%.
What makes Noah Medical unique
- Galaxy System™ uses TiLT+ Technology™ to overcome CT-to-body divergence.
- Augmented fluoro overlays target lesions on live fluoro video.
- Single-use bronchoscope prevents cross-contamination and speeds turnover.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Mental Health Support
Legal Services
Pet Insurance
12+ Paid Holidays
15-20 Days of PTO
Paid Parental Leave
In-office Snacks and Beverages
In-office Lunch Stipend
Learning & Development Opportunities
Team Building and Company Organized Social Events
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 3%MemorialCare Cancer Institute uses first-of-its-kind robotic navigated bronchoscopy for greater precision and accuracy.LAGUNA HILLS, Calif., Aug. 6, 2024 /PRNewswire/ -- MemorialCare Cancer Institute's Lung Cancer Program at Saddleback Medical Center is one of just four hospitals in California equipped with the recently FDA-cleared robotic navigated bronchoscopy system. This new device from NoahMed, Galaxy System, uses integrated tomosynthesis (3D mammography) to navigate to and locate lung nodules, which are small masses in the lungs often tested for cancer.This improved visualization, along with a disposable bronchoscope, enhances precision and accuracy beyond the capabilities of existing technologies. It gives physicians access to often hard-to-reach lesions in the outer third of the lung which are often hard to biopsy. The Galaxy System can biopsy nodules smaller than 2cm, while receiving real-time lesion location updates."Lung cancer is an insidious disease causing far too high a toll on our communities," said Jayne Stewart, executive director, MemorialCare Cancer Institute, MemorialCare Saddleback Medical Center. "The Galaxy System gives physicians trained on the device a clear, direct path to improving patient diagnosis and, in turn, treatment –allowing us to catch lung cancer before it reaches less treatable, advanced stages
Noah MedicalNext-generation robotics company and its CEO recognized separately for pioneering work, innovative new technology, and rapid progressSAN CARLOS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical announced today that it has been named a finalist in the prestigious Surgical Robotics Industry Awards 2024 alongside its founder and CEO Dr. Jian Zhang. This joint recognition highlights Noah Medical’s groundbreaking work in endoluminal robotics and Dr. Zhang’s visionary leadership within the industry.Noah Medical is a finalist in the Innovative Start-up category, which honors companies under six years old that have demonstrated significant potential and introduced innovative solutions to enhance surgical procedures and patient outcomes. Dr. Zhang is a finalist in the Industry Leadership category, awarded to those who have demonstrated outstanding business or commercial success, highly effective management, and a track record as a thought leader.Since the beginning of 2023, Noah Medical has announced $150 million in Series B funding , secured FDA clearance for The Galaxy System™, its fully image-integrated solution for robotic navigated bronchoscopy, and launched the platform to commercial and industry acclaim.The company’s proprietary technology is transforming the early identification and diagnosis of lung cancer by making it possible for physicians to overcome traditional imaging and navigation limitations to confidently reach nodules in the outer periphery of the lung
Listen to this articleNoah Medical’s Galaxy is a fully integrated surgical robotics system for navigated bronchoscopy. | Credit: Noah Medical. Medical robotics continues its impressive march forward within mainstream medicine. From new applications to new technologies, the field demonstrated impressive growth over the last year. But there’s still incredible room to grow, and looking ahead to 2024, there are a few clear areas of opportunity
SAN CARLOS, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical announced today that its Galaxy System, a fully image-integrated solution for robotic navigated bronchoscopy, was named a finalist in the 2023 Fierce Innovation Awards: Life Sciences Edition. The Galaxy System was recognized in the Medical Device Innovation category for its groundbreaking combination of innovative new technologies and features, including proprietary integrated tomosynthesis with augmented fluoroscope, a disposable single-use scope, and small footprint.Fierce Innovation Awards showcase innovations that have made an impact over the last 12 months and represent the greatest potential to transform the industry. The Galaxy System is the first of its kind and was built from the ground up based on physician feedback about the complex and life-altering decisions made during a lung biopsy procedure. With the introduction of the Galaxy System, more physicians in a broader range of clinical settings can diagnose disease earlier, ensuring patients can receive appropriate treatment at an earlier stage of the disease.“This award is a recognition of the entire team at Noah Medical, our commitment to revolutionizing medical robotics, and our work helping patients live better, healthier lives,” said Noah Medical CEO Jian Zhang. “We are honored to be praised by experts and peers within the industry for our work, we are transforming patient experiences and redefining the future of healthcare.”The Galaxy System’s “Tool-in-Lesion Tomography” or “TiLT” Technology was designed to overcome CT-to-body divergence by providing real-time lesion updates during a bronchoscopy procedure
Noah Medical’s Galaxy System is used in the US for the first time. By Brianna Wessling | May 22, 2023Listen to this articleVIDEO. Noah Medical announced that its Galaxy System, an integrated system for navigated robotic bronchoscopy, was used for the first time in the United States at the University of Chicago Medicine by Dr. Kyle Hogarth.